Women in Science: Deep Genomics’ Tehmina Masud

With an inquisitive mind and by asking endless questions, she soon found herself studying medicine and fully understanding what her dad meant when he said the future of medicine lay within genetics, mathematics and computer science. Read our interview to find out how Tehmina ended up as vice president and head of target identification at Toronto-based TechBio, Deep Genomics​.

Could you give us an overview of your work?

I lead a multidisciplinary team of statistical genetics and biology scientists, pioneering a new path for R&D. My team focuses on leveraging the company’s platform and AI/ML models to identify targets for drug discovery. Specifically, we work at the intersection of AI with biological sciences and drug development, where everyone contributes unique knowledge and perspective, enabling complex problem-solving and innovation. As a result, we are taking a new TechBio approach that enables partners to move faster and more predictably.

When did you realize you were interested in science – as a young child, teen, or older?

As a child, I was fascinated by science and grew up in a home environment that involved discussions about almost every decision. I learned to ask questions about outcomes and consequences and was drawn to problem solving. I had an inquisitive mind and was always questioning why things did or didn’t work. 

Before my teenage years, my father, who was a physicist, gave me The Double Helix by James Watson​, and a computer. He said that the future of medicine is genetics, mathematics, and computer science. He urged me to learn and study those areas. Later, as I pursued medical school, my interest in molecular biology and genetics grew exponentially, and I began to understand and truly appreciate what my father meant.

admin

admin

Leave a Reply

Your email address will not be published. Required fields are marked *